Introduction
Mucosal immunity provides the first level of defense against foreign antigens. Some mucosal pathogens, like rotavirus (RV) in the gut and respiratory syncytial virus in the respiratory tract, replicate at the site of entry and cause disease by local tissue damage (1) . In such mucosal infections, systemic memory cells are frequently unable to prevent clinical symptoms; optimal protective immunity correlates with the presence of effector cells or local antibody at mucosal sites (1, 2) . CD8 + T cell responses are a major defense against viral infections at different tissue sites. The ability of lymphocytes to traffic to relevant tissues is critical for an effective immune response and is mediated by homing receptors on effector cells that have cognate ligands at peripheral or mucosal sites (3) . Intestinal CD8 + T cell immunity, for example, has been specifically correlated with expression of α 4 β 7 integrin (4). This integrin and its ligand, mucosal adressin cell adhesion molecule (MAdCAM-1) are known to play an important role in homing of activated lymphocytes to Peyer's patches and the lamina propria (5-7). Using adoptively transferred immune CD8 + T cells in a murine RV (mRV) model, our earlier experiments supported the hypothesis that α 4 β 7 integrin expression on CD8 + T cells was critical for effective intestinal immunity (8) . In that study we demonstrated that α 4 β 7 hi but not α 4 β 7 low memory CD8 + T cells from wild-type (wt) mice that had been orally immunized were able to resolve chronic infection when transferred into Rag-2 deficient mice. It was unclear however, whether the ability of α 4 β 7 hi CD8 + T cells to resolve RV infection was solely dependent upon α 4 β 7 expression or whether it reflected a higher frequency of anti-RV immune CD8 + T cells in the α 4 β 7 hi population generated following oral immunization with RV.
Determination of the function of β7 integrins has recently been facilitated by development of a β7 gene knockout (β7 -/-) mouse (9) (10) (11) (12) (13) . These β7 -/-mice, lacking both α 4 β 7 and α E β 7 integrins, have dramatically reduced numbers of intestinal lymphocytes (9) . Whereas α 4 β 7 integrin has been implicated in lymphocyte homing to the intestine, α E β 7 integrin is believed to retain CD8 + T Rotavirus (RV), which replicates exclusively in cells of the small intestine, is the most important cause of severe diarrhea in young children worldwide. Using a mouse model, we show that expression of the intestinal homing integrin α 4 β 7 is not essential for CD8 + T cells to migrate to the intestine or provide immunity to RV. Mice deficient in β7 expression (β7 -/-) and unable to express α 4 β 7 integrin were found to clear RV as quickly as wild-type (wt) animals. Depletion of CD8 + T cells in β7 -/-animals prolonged viral shedding, and transfer of immune β7 -/-CD8 + T cells into chronically infected Rag-2-deficient mice resolved RV infection as efficiently as wt CD8 + T cells. Paradoxically, α 4 β 7 hi memory CD8 + T cells purified from wt mice that had been orally immunized cleared RV more efficiently than α 4 β 7 low CD8 + T cells. We explained this apparent contradiction by demonstrating that expression of α 4 β 7 on effector CD8 + T cells depends upon the site of initial antigen exposure: oral immunization generates RV-specific CD8 + T cells primarily of an α 4 β 7 hi phenotype, but subcutaneous immunization yields both α 4 β 7 hi and α 4 β 7 low immune CD8 + T cells with anti-RV effector capabilities. Thus, α 4 β 7 facilitates normal intestinal immune trafficking to the gut, but it is not required for effective CD8 + T cell immunity. cells in the intraepithelial compartment of the intestine (14) . Taking advantage of the existence of β7 -/-mice, we set out to investigate the functional properties of CD8 + T cells lacking α 4 β 7 expression, using an RV intestinal infection model. We specifically sought to determine whether such cells could localize at the site of RV infection and efficiently participate in antiviral immunity.
Methods
Viruses. Stocks of wt mouse RV (EC) were prepared as intestinal homogenates, and the titer (Diarrhea Dose 50 [DD 50 ]) was determined by infecting suckling mice as previously described (15) . Tissue culture-adapted rhesus RV (RRV) was prepared as described (16) . RRV inactivation was performed as previously described by Groene and Shaw (17) . Briefly, psoralen 4′-aminomethyl1-4, 5′ 8-trimethylpsoralenhydrochloride (HRI Associates, San Diego, California, USA) at a concentration of 40 µg/ml was added to 1 ml of purified RRV (titer of 5 × 10 9 focusforming units per ml) and the virus was ultraviolet (UV) inactivated for 40 minutes using UV light (George W. Gates & Co., Franklin Square, New York, USA). The lack of viral infectivity following inactivation was confirmed by virus focus assay (18) .
Mice. C57BL/6 mice were obtained from Charles River Laboratory (Hollister, California, USA). β 7 knockout (β7 -/-) mice (C57BL/6 background) were produced by Norbert Wagner (Institute for Genetics, University of Cologne) as previously described (9) . Rag-2-deficient (Rag-2) mice were obtained from Taconic Laboratories (Germantown, New York, USA). Th1.1 mice were obtained from Jackson Laboratories (Bar Harbor, Maine, USA). All mice were bred in the Palo Alto Veteran Administration vivarium. Mice were routinely tested for RV antibodies (or RV shedding for Rag-2 mice) prior to infection and tested negative.
Virus inoculation. Oral immunizations were performed as follows. Three-to five-week-old β7 -/-, Rag-2, and C56BL/6 mice were orally gavaged (using a feeding needle) with 5 × 10 5 DD 50 of mRV strain EC after receiving 100 µl of 1.33% sodium bicarbonate to neutralize stomach acid. Rag-2 mice (used as recipients for adoptive transfer) were infected 1-4 months prior to use in the cell transfer studies. Stools were collected 2 weeks after viral inoculation of Rag-2 mice to confirm the establishment of chronic infection. Systemic immunizations were performed on 4-to 5-week-old C57BL/6 mice. The mice were injected subcutaneously with 20 µg of inactivated RRV with CFA (Sigma Immuno-Chemicals, St. Louis, Missouri, USA). Fifteen days later the same animals were injected subcutaneously a second time with 20 µg/mouse of inactivated RRV in Incomplete Freund's Adjuvant (IFA) (Sigma Immuno-Chemicals).
Detection of RV antigen. For detection of RV antigen (Ag), sandwich ELISA was carried out as described previously (15) .
Detection of anti-RV antibodies. Virus-specific antibodies were detected using standard ELISA. Plates were first coated as described above and then incubated overnight at 4°C with 1:5 dilution of RRV stock. After washing, 10% stool suspensions were added to the plates and incubated overnight at 4°C as described above. Antibody was detected with horse radish peroxidase-conjugated (HRP-conjugated) anti-mouse IgA or IgG (Kirkegaard & Perry Laboratories Inc., Gaithersburg, Maryland, USA). Stools from noninfected animals were used as negative controls. The concentration of anti-RV antibodies was determined by running an IgA standard in each individual plate as described previously (19) . Briefly, three rows per plate were coated with purified goat anti-mouse IgA (Kirkegaard & Perry Laboratories Inc.) followed by blocking with 5% dry nonfat milk and washing with Tween 20 . A standard of 250 ng/ml of purified mouse IgA isotype (PharMingen, San Diego, California, USA) was serially diluted and added to the plate. The antibodies were detected using anti-mouse IgA conjugated to HRP as described above. Absorbance at 405 nm was measured to provide standard curve.
CD8 + T-cell purification, FACS sorting, and adoptive transfer experiments. RV immune β7 -/-or wt mice were used as donors for adoptive transfer of CD8 + T cells into chronically infected Rag-2 mice. Thirty days following oral infection with mRV EC, spleens from the donor mice were harvested, and cell suspensions were made using a sterile cell strainer (40 µm) (Fisher Scientific, Springfield, New Jersey USA). The splenocytes were washed with Dulbecco's modified Eagle's medium supplemented with 10% FBS (DMEM-10) and the red blood cells were lysed using lysing buffer (8.3 g/l ammonium chloride in 0.01 M tris-HCL buffer, pH 7.5). The cell suspensions were affinity purified through CD8 purification columns (R&D Systems Inc., Minneapolis, Minnesota, USA) (1-2 × 10 8 cells per column). The purity of the cells was generally 86 ± 3%. The CD8 + T cells were subsequently stained with antibodies to CD8 (Lyt2) and antibodies to T cell-receptor β chain (TCR-β chain) conjugated to FITC or phycoerythrin (PE), respectively. The cells were then sorted using a modified FACStar (Becton Dickinson Immunocytometry Systems, San Jose, California, USA) with a single 488-mm argon laser and three fluorescence detectors. To avoid possible contamination with B cells, the affinity-purified splenocytes were sorted twice. The purity after the first sort was 97-99% and after the second sort was ≥ 99.7%. Sorted cells were resuspended in sterile HBSS, and 5 × 10 5 , 5 × 10 4 , 5 × 10 3 wt, or β7 -/-CD8 + TCRαβ + T cells were injected intraperitoneally into chronically infected Rag-2 mice. The ability of the transferred cells to resolve chronic infection was determined by measuring RV Ag shedding in the stools of the recipients.
Experiments in which wt and β7 -/-CD8 + T cells were transferred simultaneously into the same recipient Rag-2 mice were also performed. To distinguish β7 -/-from wt CD8 + T cells, we used Thy1.1 wt mice in these experiments. Splenocytes from immune wt (Thy1.1) and β7 -/-(Thy1.2) mice were affinity-purified using CD8 purifi-cation column as described above and double sorted by FACS. The purity of the sorted αβ CD8 + T cells was ≥ 99.8%. A mixture of 5 × 10 5 wt Thy1.1 and 5 × 10 5 Thy1.2 β7 -/-(1:1 ratio) or 1 × 10 6 wt and 2 × 10 5 β7 -/-(1:5 ratio) CD8 + T cells were injected into chronically RV-infected Rag-2 mice. Three adoptively transferred Rag-2 recipient mice were sacrificed at each time point (days 7, 14, and 30 following the adoptive transfer). Intraepithelial lymphocytes (IELs), mesenteric lymph nodes (MLNs), and spleen cells were purified individually from each recipient Rag-2 mouse and were stained with anti-CD8 CyChrome, anti-Thy1.1 allophycocyanin (APC) and anti-Thy1.2 PE purchased from PharMingen. IEL, MLNs, and spleen cells were purified from unmanipulated Rag-2 mice (lacking B and T lymphocytes), stained with the same antibodies, and used as negative controls. The cells were analyzed using flow cytometry.
To compare the anti-rotaviral activity of CD8 + T cells generated by oral versus subcutaneous immunizations, separate groups of wt mice were immunized orally or subcutaneously as described above. Spleen cell-suspensions from immunized wt mice were enriched for CD8 + T cells by column purification, and were stained with anti-CD8 FITC, anti-α 4 β 7 PE, and biotinylated anti-CD44, purchased from PharMingen. The cells were washed and streptavidin-Red613 (Life Technologies Inc., Gaithersburg, Maryland, USA) was added to stain biotin-tagged cells. Subsequently, three-color cell sorting was performed using modified FACS-star with filters for FITC detection (530/30), for PE detection (585/42), and for Red 613 detection (630/22). The sorted cells (purity 99.5 ± 0.2%) were resuspended in sterile saline solution and 10,000 CD44 + , α 4 β 7 hi , and 30,000 CD44 + , α 4 β 7 low CD8 + T cells were injected intraperitoneally into chronically infected Rag-2 mice. Three days following adoptive transfer, control recipient mice were sacrificed and lymphocytes from spleen, MLNs, or intestinal intraepithelial lymphocytes (iIELs) were subjected to flow cytometric analysis. We were not able to detect any residual lymphocyte staining with the anti-α 4 β 7 integrin or CD8 antibodies in any of the tissues tested (data not shown).
FITC labeling of splenocytes. Splenocytes from naive β7 -/-or wt mice were labeled with FITC as previously described (20) . Frozen stocks of FITC (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany) were diluted in 50% DMEM, 50% HBSS, and 2.5% FBS, pH 7.0 to a concentration of 38 µg/ml. Five to six million spleen cells were incubated for 20 minutes with 2 ml FITC (38 mg/ml) at 37°C. The labeled spleen cells were spun through 7 ml of FBS to remove the excess FITC and subsequently washed twice with HBSS. 2 × 10 7 FITC-labeled cells were injected intravenously into naive C57BL/6 recipients.
Isolation of lymphocyte populations. iIEL populations were isolated from the recipient Rag-2 mice as described previously (21) . MLNs and spleens of the transferred immunodeficient Rag-2 mice were removed 30 days following the adoptive transfer. Single cell suspensions were prepared using a sterile cell strainer as described above.
In vivo depletion. Mice were depleted of CD8 + T cells by administration of ascites containing rat anti-mouse CD8 mAb 2.43 as previously described (22) . In brief, each mouse received 0.5 ml of ascitic fluid intraperitoneally 5, 4, and 3 days before RV infection; on the day of RV infection; and on days 3, 6, and 9 after infection. Depleted and nondepleted control mice were sacrificed at day 25 following the RV infection to detect CD8 + T cells in the spleen, MLNs, and IELs by flow cytometry. All flow cytometry data were analyzed with the CEL-LQUEST program (Becton Dickinson Immunocytometry Systems) on a Macintosh computer (Apple Computer Inc., Cupertino, California, USA).
ELISPOT for RV-specific cytokine producing cells. The method used was described in detail previously (23) . Splenocytes from subcutaneously or orally immunized animals were analyzed for IFN-γ spot-forming (SF) cells. Splenocytes were passed through a CD8 purification column and subsequently separated by FACS into α 4 β 7 hi and α 4 β 7 low populations. To generate cytokines, the purified CD8 + T cells were stimulated with enriched dendritic cell (DC) populations obtained as described by Nair et al. (24) . Splenocytes from naive 8-to 10-weekold female C57BL/6 mice were depleted of erythrocytes, and 3 ml of cells at concentration 1 × 10 7 per ml were layered over 2 ml of a metrizamide gradient (Nycomed Pharma A, Oslo, Norway; analytical grade,14.5 g added to 100 ml of PBS, pH 7.0). The cells were then centrifuged at 600 g for 10 minutes, and the cells at the interface were collected. The enriched DC populations were pulsed for 4 hours with cesium-purified, psoralentreated, and UV-inactivated RRV (50 µg/1 × 10 6 DCs) and used as stimulators. The responder FACS purified CD8 + α 4 β 7 hi or α 4 β 7 low T cell populations and the stimulators were mixed at stimulator/responder ratios of 50:1, 25:1, and 12.5:1 in 200 µl of 10% FBS DMEM and plated into coated and blocked ELISPOT plates. The ELISPOT plates were precoated with anti-IFN-γ) (PharMingen) at a concentration of 2 µg/ml in 100 µl of sterile carbonate buffer and incubated at 4°C overnight. Subsequently the plates were blocked with DMEM 10% FBS for 1 hour at 37°C. After 72 hours of incubation of the effector and stimulator cells (in a vibration-free incubator), the ELISPOT plates were washed and biotinylated anti-IFN-γ antibody (PharMingen) diluted 1:10000 in PBS 1% FBS was added to the plate. After 1 hour of incubation at 37°C the plates were washed, streptavidin-conjugated alkaline phosphatase (diluted 1:2000) was added, and the plates were incubated at 37°C for an additional 1 hour. Subsequently the plates were developed using nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-inodolyl phosphate (BCIP) (Sigma Immuno-Chemicals) substrates and the spots were counted 24 hours later using a dissecting microscope.
Quantification of anti-RV CD8 + T cells with VP-7 specific tetramers.
The RV-specific MHC I (H-2K b ) restricted tetramer was constructed as previously described (25) . In brief, the recombinant MHC molecule was folded in the presence of mouse β2-microglobulin and a rotaviral VP7 peptide epitope (IVYRFLLV) (previously shown to contain the dominant H-2K b restricted CD8 T-cell epitope in C57BL/6 mice [ref. 26] ) to form a peptide-MHC complex, following the procedure of Garboczi et al. (27) . After biotinylation using the enzyme BirA, the complex was mixed with APC-conjugated streptavidin (PharMingen) at molar ratios of 4:1 to form the peptide MHC tetramer.
For four-color FACS analysis, a mixture containing RV-specific tetramer conjugated to APC (2 µg), anti-CD8 Cy-Chrome (0.5 µg), FITC-labeled antibodies to CD13, CD4, and CD19 (0.5 µg), and anti-α 4 β 7 PE (0.5 µg) was added to 1 × 10 6 spleen cells. After 30 minutes of incubation at room temperature in the dark, the cells were washed with FACS buffer (PBS 2.5% BCS, 0.1% Na Azide), fixed in 1% paraformaldehyde, and analyzed on a FACScalibur flow cytometer.
Immunofluorescence. Seven-micron cryosections from ileum of selected mice were fixed for 8 minutes in acetone at 4°C. Sections were then blocked with 10% normal hamster serum (Jackson ImmunoResearch Laboratories Inc., West Grove, Pennsylvania, USA) for 30 minutes. Slides were incubated for 5 hours at room temperature with biotinylated hamster anti-mouse CD3ε at 1.33 µg/ml (PharMingen). After washing three times for 5 minutes each, streptavidin-conjugated Texas Red (Jackson ImmunoResearch Laboratories Inc.) was added at 1:300 and incubated for 1 hour in the dark at room temperature. Slides were washed three times for 5 minutes each, coverslipped with vectashield (Vector Laboratories, Burlingame, California, USA) and analyzed with a scanning confocal microscope. Negative controls included omission of the primary antibody or replacement of the primary antibody with an isotype-matched hamster IgG 2a antibody.
Results

β7 -/-mice clear primary RV infection with the same efficiency as wt mice.
Following oral infection with mRV, the level of RV shedding and anti-RV antibody secretion in the stool was determined from fecal samples collected from β7 -/-or wt (C57BL/6) mice. β7 -/-mice developed significantly less intestinal anti-RV IgA compared to wt mice following oral RV infection (Figure 1a) . Despite diminished intestinal humoral immunity, β7 -/-mice were able to resolve primary RV infection at the same rate as wt animals ( Figure 1b) .
To determine whether resolution of primary RV infection in β7 -/-mice was CD8 + T-cell dependent, β7 -/-mice were depleted of CD8 + T cells using mAb's (see Methods). Antibody-treated mice exhibited a substantial reduction in the number of CD8 + T-cells in the iIEL compartment, confirming successful depletion ( Figure  2a) . Accordingly, CD8 + T cell-depleted mice exhibited significant prolongation of RV shedding compared with nondepleted β7 -/-mice ( Figure 2b ). The duration of rotaviral Ag shedding was similar to that in CD8 + T cell-depleted wt mice (data not shown, and ref. 28 ). These results indicate that, as in wt mice, CD8 + T cells are involved in the timely resolution of primary RV infection in β7 -/-mice.
Immune CD8 + T cells resolve RV infection when transferred from β7 -/-mice into chronically infected Rag-2 deficient mice.
We used an adoptive transfer approach to evaluate the influence of α 4 β 7 expression on the effector function of CD8 + T cells. As previously described (29), Rag-2 mice become chronically infected when orally inoculated with mRV ( Figure 3a) . These mice were used as recipients for CD8 + splenic T cells derived from β7 -/-or wt mice that had previously cleared RV. The ability of adoptively transferred CD8 + T cells to resolve chronic RV infection was monitored by measuring daily RV shedding in stools of recipient Rag-2 mice. Adoptive transfer of 5 × 10 3 immune β7 -/-or wt CD8 + T cells into infected Rag-2 mice failed to clear RV infection ( Using flow cytometry, CD19 + (B cells) and CD4 + cells were not detected in the Rag-2 mice following transfer with immune CD8 + T cells, confirming that the donor cells were not contaminated (data not shown). The absence of B cell contamination was further supported by the observation that anti-RV IgA remained undetectable in the stool of Rag-2 mice 30 days after CD8 + T-cell transfer (data not shown). Hence we were unable to show a quantitative or qualitative difference in the effector function of β7 -/-versus wt CD8 + T cells.
α 4 β 7 -/-CD8 + T cells can migrate to the IEL compartment of chronically infected Rag-2 mice. To determine whether the α 4 β 7 deficient CD8 + T cells migrated into the intestinal epithelium, the percentage of CD8 + TCRαβ + cells in the iIEL compartment of Rag-2 mice was evaluated at day 30 following adoptive transfer (Figure 4 ). For comparison, the percentage of TCRαβ + CD8 + cells in the spleen and MLNs was also determined since lymphocyte migration to these organs is not dependent on α 4 β 7 integrin expression.
As anticipated, wt mice possessed CD8 + T cells in all three compartments (iIEL, MLNs, and spleen) while the treated Rag-2 mice had virtually no detectable TCRαβ + cells in any of these compartments. In contrast, on day 30 following RV clearance, CD8 + αβ + donor T cells were detected in iIEL, spleen, and MLNs of Rag-2 mice regardless of whether they expressed α 4 β 7 integrin (Figure 4) .
A somewhat lower percentage of lymphocytes was recovered from the iIEL compartment of chronically infected Rag-2 mice reconstituted with purified CD8 + TCRαβ + cells from β7 -/-mice (14.7%) than from wt mice (34.0%) (Figure 4) . The absolute number of cells recovered from iIEL of chronically infected Rag-2 mice at day 30 following adoptive transfer of β7 -/-or wt CD8 + T cells was similar (in the range of 2-6 × 10 6 cells per mouse). When the percentages of CD8 + T cells in iIELs from six animals per group were compared (wt versus β7 -/-) the differences were not statistically significant (P > 0.05) (using Student t test) (see Figure 7d) . To test whether migration into the intestinal mucosa of α 4 β 7 integrin-deficient CD8 + T cells occurred independently of α 4 β 7 ligand binding, we examined the competition for iIEL entry between α 4 β 7 -deficient and wt CD8 + T cells. We used wt (Thy1.1) and β7 -/-(Thy1.2) mice as donors. Thirty days following RV infection of wt (Th1.1) or β7 -/-(Th1.2) mice splenic CD8 + T cells were affinity-purified and double FACS sorted (purity ≥ 99.8%). A mixture of 5 × 10 5 β7 -/-and 5 × 10 5 wt CD8 + T cells was adoptively transferred into the same Rag-2 recipients. The recipients were sacrificed at 14 days following adoptive transfer (when viral infection had cleared from the intestine) and the percentages of β7 -/-or wt CD8 + T cells in the iIEL were determined using flow cytometry. In all adoptively transferred Rag-2 mice we observed distinct populations of β7 -/-and wt CD8 + T cells in both iIEL and MLN compartments ( Figure 5, a and b) . The percentage of β7 -/-T cells in the iIEL was ten times lower than wt CD8 + T cells (Figure 5a ). When five times more wt than β7 -/-T cells were transferred, we were still able to detect α 4 β 7 deficient CD8 + T cells in the iIEL (percentages were from 15-to 20-fold lower than wt T cells, data not shown). These findings suggest that α 4 β 7 -deficient T cells were able to migrate to iIEL even in the presence of competing wt CD8 + T cells, consistent with the notion that they were trafficking into the iIEL via an alternative recognition signal.
Histological analysis of intestinal tissues from RVchallenged Rag-2 mice in the presence or absence of adoptively transferred β7 -/-or wt CD8 + T cells. Immunohistological examination of intestinal tissue from adoptively transferred Rag-2 mice was performed to determine the location of adoptively transferred lymphocytes. RV-infected Rag-2 mice, reconstituted with immune CD8 + T cells from β7 -/-or wt mice, were sacrificed at day 30 after adoptive transfer, and sec- were treated or untreated with anti-CD8 mAb. β7 -/-mice were depleted of CD8 + T cells and subsequently infected with RV as described in Methods. At day 25 from the beginning of the experiment, the mice were sacrificed and IEL, MLNs, and spleen cells were purified, stained with anti-CD8 and anti-TCRαβ antibodies, and analyzed by FACS. (b) Stool samples were collected daily following RV infection, and the levels of RV Ag were determined by ELISA. SD is based on four animals per group (the figure represents one out of two experiments performed with similar results).
tions of ileum were used for histological analysis. Intestinal sections from wt and untreated Rag-2 mice served as controls ( Figure 6, a and b) . CD3 + cells were detected in the iIEL compartment of wt mice ( Figure  6a ) but, as expected, not in mice that were Rag-2 (Figure 6b) . On the other hand, Rag-2 mice that received wt or β7 -/-CD8 + T cells demonstrated CD3 + cells in both IEL and lamina propria (LP) compartments of the intestine (Figure 6, c and d) .
The time of reconstitution of the IEL compartment with β7 -/-or wt CD8 + T cells correlates with resolution of RV shedding. To follow the migration of the transferred β7 -/-or wt CD8 + T cells in chronically infected Rag-2 mice, recipients were sacrificed at different time points after cell transfer and IEL, MLNs, and spleen cells were analyzed by flow cytometry (Figure 7) . At 3 hours (Figure 7a ) and 3 days (data not shown) after transfer, the highest percentage of transferred CD8 + αβ + T cells was found in the spleen (and blood, data not shown). By 7 days after transfer, the highest percentage of transferred immune cells was detected in the MLNs, but none were detected in the iIEL (Figure 7b ). Correspondingly, rotaviral replication in the intestine continued during the same period ( Figure 3, f and g ). By day14, β7 -/-and wt CD8 + αβ + T cells were detected in the IEL of the respective recipient Rag-2 mice ( 
CD8 + T cells. Differences in percentages of CD8 + T cells in iIEL between groups (each composed of six animals)
were not statistically significant (P > 0.05), however ( Figure 7 , c and d).
Oral immunization with live mRV generates RV-specific CD8 + T cells in the α 4 β 7 hi memory cell population whereas subcutaneous administration of inactivated RRV generates anti-RV CD8 + effectors with both α 4 β 7 low and α 4 β 7 hi phenotypes. The experiments described above demonstrate that α 4 β 7 expression is not a requirement for CD8 + T cell-mediated immunity against RV in the intestinal mucosa. However, in an earlier study we showed that α 4 β 7 hi CD8 + splenic T cells from orally infected wt mice resolved chronic RV infection more efficiently in Rag-2 mice than α 4 β 7 low cells (8) . Given our new findings with β7 -/-mice, we postulated that the reason we had not observed effective antirotaviral immunity with α 4 β 7 low spleen cells (see Figure  10a and ref. 8) might be due to the presence of fewer RV-specific CD8 + T cells in α 4 β 7 low versus α 4 β 7 hi subsets following oral immunization rather than a low level of intestinal homing integrin expression in the α 4 β 7 low population. Therefore we quantified the number of RVspecific CD8 + T cells in the splenic populations of donor mice. These were the cells used for adoptive transfer into RV infected Rag-2 mice. We specifically determined the frequency of anti-RV splenic CD8 + T cells in α 4 β 7 hi and α 4 β 7 low populations following oral versus subcutaneous immunization with RV.
Wt mice were immunized orally with live mRV or subcutaneously with inactivated RRV in CFA and IFA (as described in Methods). Systemic immunization was employed with the hope that RV immune CD8 + T cells might be induced efficiently in the α 4 β 7 low population. For systemic immunizations, inactivated RRV was used because this virus, in contrast to mRV, does not spread to the intestine when administered subcutaneously. To further eliminate this possibility, we chemically treated and UV-inactivated the RRV. Successful inactivation was confirmed by demonstrating lack of viral replication in the inactivated RRV preparations when cultured in vitro (data not shown).
Two approaches were adopted to determine the frequency of RV-specific CD8 + T cells in the immunized mice: ELISPOT assay and staining of Ag-specific CD8 + T cells using an MHC class I tetramer. Thirty days following immunization, we determined the frequency of IFN-γ SF CD8 + T cells (23) from systemically or orally immunized mice after in vitro restimulation. Oral immunization generated 26 IFN-γ SF CD8 + T cells/10 4 α 4 β 7 hi CD8 + T cells, whereas only two IFN-γ SF CD8 + T cells were detected in the α 4 β 7 low population (Figure 8 ). On the other hand, systemic administration with inactivated RV generated IFN-γ-producing cells at a frequency of 4 and 10 SF cells/1 × 10 4 CD8 + T cells in the α 4 β 7 hi and α 4 β 7 low populations, respectively (Figure 8 ). The high ratio of α 4 β 7 hi to α 4 β 7 low RV-specific CD8 + T cells (26:2) was confirmed using class I restricted tetramer staining (Figure 9) . A higher percentage of RVspecific CD8 + T cells was found in the α 4 β 7 hi fraction of orally immunized animals (0.16%), consistent with our previous ELISPOT results, whereas very few RV-specific CD8 + T cells were detected in the α 4 β 7 low fraction (0.03%). In contrast, both assays demonstrated that subcutaneous immunization generated RV-specific CD8 + T cells in both α 4 β 7 hi and α 4 β 7 low populations (0.23% and 0.22% by tetramer analysis [ Figure 8 ] and 4 ± 2 and 10 ± 4 by ELISPOT analysis [ Figure 9] ). α 4 β 7 low CD8 + T cells from subcutaneously immunized wt donor mice can eliminate RV infection from chronically infected Rag-2 recipients. We next tested the in vivo ability of α 4 β 7 hi and α 4 β 7 low CD8 + T cells purified from subcutaneously versus orally immunized mice to clear RV when transferred into chronically infected Rag-2 mice. Initially we confirmed our previous studies (8) demonstrating that 10,000 purified α 4 β 7 hi CD8 + T cells from orally immunized wt mice efficiently resolved chronic RV infection when transferred into Rag-2 mice (Figure 10c ), whereas 30,000 α 4 β 7 low CD8 + T cells (threefold more) from the same donors could not resolve infection (Figure 10a ). In contrast, 30,000 α 4 β 7 low CD8 + T cells transferred from subcutaneously immunized wt mice efficiently resolved RV infection in Rag-2 mice (Figure 10b ). Although both α 4 β 7 low and α 4 β 7 hi cell populations underwent homeostatic expansion in the recipient Rag-2 mice (similar number of cells were recovered from the spleen MLNs and iIEL compartments, data not shown), only α 4 β 7 hi CD8 + T cells were able to resolve RV infection ( Figure  10b ). These results demonstrate that subcutaneous RV immunization generated protective anti-RV CD8 + T cells in the α 4 β 7 low population.
Discussion
This study demonstrates that α 4 β 7 integrin expression on memory CD8 + T cells is not essential for those cells to migrate to the gut and resolve RV infection. Our results suggest the existence of a β7-independent mechanism of CD8 + T cell migration to and/or retention in the intestine. This alternative mechanism appears sufficient to direct and/or retain CD8 + TCRαβ + cells to intestinal effector sites in the absence of both α 4 β 7 and α E β 7 integrin expression. We also provide evidence that oral immunization with live RV generates Ag-specific CD8 + T cells almost exclusively in the α 4 β 7 hi population, whereas subcutaneous RV administration induces a more divided CD8 + T cell immune response in both α 4 β 7 hi and α 4 β 7 low cell fractions. Previous studies have specifically correlated intestinal lymphocyte homing with expression of the α 4 β 7 integrin. In vitro and short-term in vivo experiments have shown the importance of α 4 β 7 in lymphocyte homing to Peyer's patches (PP) and intestinal LP (3, 5-7, 30, 31) . In vivo experiments demonstrated more efficient homing of α 4 β 7 hi versus α 4 β 7 low memory T cells to PP (7) . A recent report using gene targeting to disrupt β 7 integrins led to drastically impaired formation of the gut associated lymphoid tissue, due to the inability of β 7 integrin deficient lymphocytes to efficiently migrate through the high endothelial venules into this compartment (9) .
Here, using β7-deficient animals and intestinal RV infection, we assessed the role played by α 4 β 7 integrin expression in promoting CD8 + T cell effector function in the gut. Because in mice, as well as in humans, RV replication is localized to the villus tips of the intestinal epithelium, the RV mouse model is particularly helpful in identifying key components of mucosal immune effector function.
Consistent with the observation that β7 -/-mice have a defective gut inductive immune system (9), β7 -/-mice orally infected with RV generated lower levels of intestinal anti-RV IgA compared to wt controls (Figure 1) . Despite diminished antiviral humoral responses, β7 -/-mice cleared RV from the intestine at the same time as wt animals (day 7 following infection), suggesting the efficient involvement of class I mediated T-cell immunity. β7 -/-mice depleted of CD8 + T cells were able to clear RV days 10 after infection just like CD8 + T cell-depleted wt mice (28) . The prolongation of RV shedding in CD8 + T cell-depleted versus nondepleted β7 -/-mice indicates that β7 -/-CD8 + T cells contribute to the timely clearance of RV during primary infection despite the absence of α 4 β 7 integrin expression. Although fewer CD8 + T cells are found in the iIEL of β7 -/-compared with wt mice (Figure 2a ), these cells appear to be sufficient to hasten the elimination of virus from the intestinal epithelium during primary infection (Figure 2b ). It is possible that during primary infection β7 -/-CD8 + T cells already present in the intestine become primed locally and subsequently clear RV infection. To directly evaluate the anti-RV function of CD8 + T cells lacking α 4 β 7 and α E β 7, we used an adoptive transfer mouse model. We used β7 -/-mice as a source of immune CD8 + T cells and compared their anti-RV effector function with that of wt CD8 + T cells after passive transfer. We injected log order differences (5 × 10 3 , 5 × 10 4 , and 5 × 10 5 ) of β7 -/-or wt CD8 + TCRαβ + cells into chronically infected Rag-2 mice and compared the kinetics and efficiency of viral clearance. We could not detect a difference either in the level or duration of RV Ag shedding between chronically infected Rag-2 mice injected with β7 -/-or wt CD8 + T cells (Figure 3) . Although a small difference in efficiency could have been missed in our analysis, β7 -/-CD8 + T cells did not appear to be substantially less efficient than wt cells in mediating antiviral function in the intestine.
We purified iIELs of the recipient Rag-2 mice at different time points following CD8 + T cell transfer and analyzed them by flow cytometry to determine whether the injected β7 -/-CD8 + T cells were actually migrating to the site of viral replication. CD8 + TCRαβ + T cells were found in the iIEL compartment of the recipient Rag-2 mice at time points synchronous with, but not before, virus elimination. At 3 hours, 3 days, and 7 days after cell transfer, CD8 + T cells were found in both spleen and MLNs, but, if present in iIEL compartment, their frequency was too low to resolve RV infection or to be detected by flow cytometry (Figure 7) . Recovery of CD8 + T cells from the iIEL compartment correlated temporally with viral clearance from the intestine. β7 -/-CD8 + T cells could still migrate to the intestine even when adoptively transferred simultaneously with wt CD8 + T cells into the same recipients ( Figure 5 ). This observation indicated that α 4 β 7 -deficient CD8 + T cells were not blocked by wt CD8 + T cells migrating into the intestine and further supports the existence of an α 4 β 7 -independent mechanism of CD8 + T cell migration into the gut epithelium.
Our findings are consistent with a recent report using class I restricted ovalbumin (OVA) transgenic mice and systemic infection with recombinant Vesicular Stomatitis Virus expressing OVA (rVSV OVA) to study the role of the α 4 β 7 and α E β 7 integrins in intestinal homing (13) . This study also identified some residual ability of β7 -/-cells to migrate to the gut. It was unclear, however, whether the residual ability of β7 -/-memory cells to migrate to effector sites would be sufficient to exert an immune effector function during intestinal infection. In the present study, using a common gut pathogen, we demonstrated that β7 -/-CD8 + T cells, when compared with wt CD8 + T cells, are able to mediate anti-RV activity in the intestine with similar efficiency during primary infection and adoptive transfer (Figures 1, 2, and 3) .
The successful function of β7 -/-CD8 + T cells in the gut, as demonstrated here, provides further evidence for redundancy within the immune system and points to the existence of an alternative mechanism of CD8 + T cell trafficking to and/or retention at intestinal effector sites. Molecules other than β7 seem likely to be involved in directing CD8 + T cells to RV-infected intestinal epithelium. For example, β2 integrins have been suggested as candidates for directing intestinal CD8 + T cells (32) , a possibility we are currently investigating. This would be consistent with the multistep model of lymphocyte homing in which α 4 β 7 integrins initiate gut homing and are thought to have serial but partially overlapping functions in vascular endothelial recognition (33) .
Recently it has been demonstrated that intestinal RV infection in young mice can induce expression of various chemokines by intestinal epithelial cells (34) . A CC chemokine, thymus expressed chemokine (TECK), and its receptor CCR9 (predominantly expressed on memory α 4 β 7 + , CD4 + , and CD8 + T cells) are selectively expressed in the small intestine, implying a potential role in intestinal immunity (35) . It is possible that RV-induced chemokines could additionally activate and recruit β7 -/-CD8 + T cells in the intestine, facilitating their local expansion. Future studies will be designed to explore this possibility.
In contrast to the ability of β7 -/-and wt CD8 + T cells to resolve RV infection when injected into chronically infected Rag-2 mice, α 4 β 7 low CD8 + T cells purified
Figure 9
Tetramer staining for RV-specific CD8 + T cells. RV-responsive cells are mainly in α 4 β 7 hi population of orally but not subcutaneously immunized mice. Wt mice (C57BL/6) were immunized twice at a 15-day interval either subcutaneously or orally with RV as described. Thirty days following the last immunization, the splenocytes from immune mice were stained with anti-CD8 CyChrome; anti-CD19, anti-CD13, and anti-CD4 FITC; anti-α 4 β 7 PE; and class I tetramer APC. Small lymphocytes were negatively gated on FITC-stained cells and positively gated on anti-CD8 CyChrome-stained cells. The gated cells were analyzed for α 4 β 7 PE expression and tetramer-APC binding. Splenocytes from nonimmunized mice were stained simultaneously and were used as negative control. As negative control we also used APC-conjugated class I tetramer specific for irrelevant Ag. The gates for α 4 β 7 -negative cells and α 4 β 7 -expressing cells were set using splenocytes from β7 -/-mice. The data represent one out of three experiments performed with similar results. Three mice per group were used in each experiment. from orally immunized immunocompetent mice were much less efficient than α 4 β 7 hi CD8 + T cells at clearing RV infection (8) . Based on our results with β7 -/-mice, we hypothesized that this difference might not reflect a requirement for α 4 β 7 expression on memory CD8 + T cells, but rather resulted from selective enrichment of RV-specific memory CD8 + T cells in the α 4 β 7 hi subset after oral immunization. In this study we provided evidence that the α 4 β 7 low population of CD8 + T cells purified from orally immunized mice was not protective when transferred into RV-infected Rag-2 mice because it contained very few RV-specific immune CD8 + T cells (Figures 8 and 9 ). We were able to increase the frequency of RV-specific CD8 + T cells in the α 4 β 7 low population by subcutaneous immunization with inactivated RV. Using this immunization route, we observed that 30,000 purified memory α 4 β 7 low CD8 + TCRαβ + T cells were able to resolve RV infection when injected into chronically infected Rag-2 mice, whereas the opposite was observed after adoptive transfer of α 4 β 7 hi CD8 + TCRαβ + T cells from orally immunized animals.
To determine the frequency of RV-specific CD8 + T cells in the α 4 β 7 hi and α 4 β 7 low populations of orally and systemically immunized animals, we used two assays: RV (VP7) specific class I restricted tetramer staining and Ag-specific IFN-γ ELISPOT assay. Both approaches demonstrated that oral immunization generated anti-RV CD8 + T cell immunity almost exclusively in the α 4 β 7 hi population. A substantial increase in the frequency of RV-specific CD8 + T cells in the α 4 β 7 low fraction was achieved when inactivated RRV was injected systemically. Hence the principle reason α 4 β 7 low CD8 + T cells from orally immunized mice fail to eradicate chronic RV infections is that they contain few, if any, RV-specific memory cells. These data are consistent with our previous study in humans demonstrating that anti RV CD4 + T cell immunity also resides primarily in the α 4 β 7 hi population (36) . In addition, we have shown that oral immunization of mice with live RV generates RV-specific Ig producing cells (measured by RV-specific ELISPOT) primarily in the α 4 β 7 hi B cell populations (37) . It is widely assumed that systemic immunity is best induced by parenteral immunization, whereas mucosal responses are generated as a result of Ag exposure at mucosal surfaces. Our data support this notion. However we also demonstrate that systemic (subcutaneous), but not oral immunization can prime protective anti-CD8 + T cell immunity in α 4 β 7 low , as well as α 4 β 7 hi , populations. Hence, induction of immune α 4 β 7 hi and α 4 β 7 low CD8 + T cells does occur after systemic immunization. On the other hand, oral immunization strongly favors the induction of α 4 β 7 hi immune CD8 + T cells with little immunity residing in the α 4 β 7 low population. Surprisingly, local RV immune effector functions can be mediated by either fraction of CD8 + T cells. Whether this is true for other CD8 + T cell-mediated local anti-microbial effects remains to be determined. It will also be important to determine if B cells with low or absent α 4 β 7 expression can mediate anti-RV effects, since the ability to induce efficient humoral mucosal effector function following systemic immunization would widen the possibility for the design of vaccines against mucosal pathogens.
